Brian Leuzzi
IFOM(IT)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Endoplasmic Reticulum Stress and Disease
Most-Cited Works
- → Endoplasmic reticulum stress signalling – from basic mechanisms to clinical applications(2018)976 cited
- → Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy(2018)285 cited
- → B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements(2025)4 cited
- → Structure-based design of potent and selective inhibitors of the HECT ligase NEDD4(2025)3 cited
- → Supplementary Table S3 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements(2025)
- → Supplementary Table S2 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements(2025)
- → Supplementary figure S3 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements(2025)
- → Supplementary figure S4 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements(2025)
- → Supplementary figure S5 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements(2025)
- → Supplementary Table S5 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements(2025)